Welcome to our dedicated page for Evolv Technologies Hldngs SEC filings (Ticker: EVLV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Evolv Technologies Holdings, Inc. filings document the public-company disclosures of an AI-based security screening business with Class A common stock and warrants listed on Nasdaq. Its Form 8-K reports include financial-results releases, Regulation FD disclosures, board and officer changes, stockholder meeting results, credit-agreement disclosures and registration-statement amendments tied to resale securities and warrant exercises.
Proxy materials describe director elections, executive compensation, auditor ratification, board committee matters and shareholder voting procedures. The filings also identify capital-structure elements, including Class A common stock, warrants and subsidiary borrowing arrangements, alongside governance and reporting matters for Evolv’s screening technology operations.
Evolv Technologies Holdings director Michael Ellenbogen reported an exercise-and-sell transaction in Class A Common Stock. He exercised stock options for 80,745 shares at $0.24 per share and sold 80,745 shares at a weighted average price of $5.63 per share under a pre-arranged Rule 10b5-1 trading plan entered into on June 12, 2025, with sale prices ranging from $5.53 to $5.77. Following these transactions, he directly owns 2,083,961 shares and indirectly holds 151,135 shares through the Family Horizon Trust.
Evolv Technologies Holdings is clarifying that some market data sites misreported its recent revenue figures and outlook. The company confirms Q1 2026 total revenue was $46.3 million, up from $32.0 million in Q1 2025, a 45% year-over-year increase.
Evolv also confirms it has raised its full-year 2026 total revenue guidance range to $175 million to $180 million. The update is meant to ensure investors are relying on the company’s own disclosures rather than incorrect third-party data.
Evolv Technologies Holdings is clarifying that some market data sites misreported its recent revenue figures and outlook. The company confirms Q1 2026 total revenue was $46.3 million, up from $32.0 million in Q1 2025, a 45% year-over-year increase.
Evolv also confirms it has raised its full-year 2026 total revenue guidance range to $175 million to $180 million. The update is meant to ensure investors are relying on the company’s own disclosures rather than incorrect third-party data.
Evolv Technologies Holdings reported first-quarter 2026 revenue of $46.3 million, up from $32.0 million a year earlier, driven by product, subscription, and service growth. The company recorded a net loss of $5.0 million, compared with a $1.7 million loss in 2025, as operating expenses and non-cash items offset higher gross profit.
Cash, cash equivalents, and marketable securities totaled $61.1 million as of March 31, 2026, with $30.0 million of term debt outstanding and an additional $45.0 million available under its credit facilities. Management believes this liquidity, plus expected cash from operations, will fund at least 12 months of needs.
The company remains in compliance with financial covenants under its MidCap credit agreement, including an Annual Recurring Revenue requirement of $107.3 million. Evolv has a $15.0 million securities Class Action settlement preliminarily approved, largely covered by $14.3 million of expected insurance recovery, and has agreed in principle to settle related derivative suits through governance reforms funded by insurers.
Evolv Technologies Holdings reported strong first quarter 2026 results with revenue of $46.3 million, up 45% from $32.0 million a year earlier, driven by new customers and expanded deployments. Ending ARR reached $127.3 million, a 20% year-over-year increase, underscoring growth in recurring subscription-based business.
The company posted a net loss of $5.0 million, or $0.03 per share, compared with a $1.7 million loss, or $0.01 per share, in the prior-year quarter, but improved profitability on an adjusted basis. Adjusted EBITDA rose to $3.9 million from $2.1 million, delivering an 8.5% margin.
Management raised its 2026 total revenue outlook to a range of $175 million to $180 million, reflecting about 20% to 23% year-over-year growth, while reaffirming expectations for year-end ARR of $145 million to $150 million and positive full-year adjusted EBITDA with high single-digit margins.
Evolv Technologies Holdings, Inc. Chief Financial Officer George C. Kutsor reported routine equity compensation activity. He exercised restricted stock units to acquire 138,888 shares of Class A common stock, then sold 51,448 shares at a weighted average price of $7.27 per share.
According to the filing, the sale was made solely to cover withholding taxes tied to RSU vesting, rather than as a discretionary stock sale. After these transactions, he directly holds 87,440 shares of Class A common stock and 277,778 RSUs, which vest in three equal annual tranches, each RSU representing a right to receive one share.
Evolv Technologies Holdings, Inc. is asking stockholders to vote at its virtual 2026 annual meeting on electing two Class II directors, approving an advisory say-on-pay resolution, and ratifying PricewaterhouseCoopers LLP as auditor. Holders of Class A common stock as of April 24, 2026 may vote online or by proxy.
The company highlights strong 2025 performance, with revenue of $145.9 million, 40% growth driven by nearly 250 new customers and over 8,000 active systems. Annual Recurring Revenue reached $120.5 million, while net loss narrowed to $33.1 million and Adjusted EBITDA turned positive at $11.1 million. Cash and marketable securities totaled $69.0 million.
The Board emphasizes enhanced governance, including an independent chair, fully independent key committees, refreshed charters, anti-hedging and clawback policies, and director and executive stock ownership guidelines. Executive pay is positioned as performance‑driven, relying heavily on at‑risk incentives, market-based stock units, and rigorous financial targets, and previously received 98% stockholder support in 2025’s say‑on‑pay vote.
Evolv Technologies Holdings, Inc. Schedule 13G/A shows a joint filing by multiple General Catalyst entities regarding Class A Common Stock (CUSIP 30049H102). The filing identifies the reporting persons and their Delaware organization structure and cites a Joint Filing Agreement governing a coordinated filing under Rule 13d-1(k). Item 5 states ownership of 5 percent or less of a class. Specific share counts and percentages refer readers to the cover sheets (Line 9/11) rather than the main text shown.
Evolv Technologies Holdings director Michael Ellenbogen exercised stock options and sold shares in a routine, pre-planned transaction. He exercised 80,745 stock options at an exercise price of $0.24 per share, receiving the same number of Class A Common shares.
On the same day, he sold 80,745 Class A Common shares at a weighted average price of $6.32 per share under a Rule 10b5-1 trading plan. After these transactions, he directly owned 2,083,961 Class A Common shares and indirectly held 151,135 shares through the Family Horizon Trust.